”Boston 2018 : 21st Century Trends in Drug Development”
Citoxlab team is pleased to invite you to its 2018 Symposium!
The drug development landscape has witnessed a broadening of targets and indications, the emergence of promising new classes of therapeutics, but also an evolving regulatory framework. This symposium will present current and novel drug safety testing approaches and the underlying regulatory toxicology strategies. The sessions cover the full spectrum from early discovery to late stage investigations and across a wide range of portfolios but all focused on non-clinical drug safety testing. From de-risking panels to regulatory filing and from clinical hold lifting approaches to case studies, this symposium will engage dynamic yet pragmatic discussion on real-life drug safety testing challenges!
When : September 13, 2018
Where : DoubleTree Suites by Hilton Boston Hotel in Cambridge, MA.
Registration: Click on this link top Register . Space are limited!
PRELIMINARY AGENDA :
09:30 am – 10:00 am : Welcome coffee
11:05 am – 11:20 am : Break
12:00 pm – 01:15 pm : Lunch
02:35 pm – 02:50 pm : Break
04:00 pm – 05:30 pm : Cocktails
Please note that this complimentary event is by invitation only, and includes lunch, refreshment breaks and afternoon cocktails.
Monika Chabicovsky, PhD, MC Toxicology Consulting GmbH : ”Toxicity and Safety Testing with CRISPR/Cas-Based Therapeutics”
Denis Roy, PhD, SciLucent, LLC : ”Nonclinical Regulatory Hurdles and Challenges in Developing Cell and Gene Therapies”
David J. Pepperl, PhD, Biologics Consulting : ”Challenges and Strategies in Nonclinical Evaluation of Novel Cancer Immunotherapies”
Guillaume Ravel, PharmD, PhD, Sanofi Pasteur : ”Nonclinical Safety Considerations for the Development of Anti-infectious Vaccines and Monoclonal antibodies”
Click on this link top Register . Spaces are limited!
Registration includes lunch, refreshment breaks and afternoon cocktails.
Please feel free to call us at Citoxlab (450-973-2240 ext 2206) with any questions.